Study Name: A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma
12 locations found
- GSK Investigational Site
Location: Fort Myers, Florida 33916
- GSK Investigational Site
Location: Tampa, Florida 33612
- GSK Investigational Site
Location: West Palm Beach, Florida 33401
- GSK Investigational Site
Location: Boston, Massachusetts 02114
- GSK Investigational Site
Location: Boston, Massachusetts 02215
- GSK Investigational Site
Location: New York, New York 10065
- GSK Investigational Site
Location: Cincinnati, Ohio 45242
- GSK Investigational Site
Location: Philadelphia, Pennsylvania 19104
- GSK Investigational Site
Location: Nashville, Tennessee 37203
- GSK Investigational Site
Location: Scottsdale, Arizona 85259
- GSK Investigational Site
Location: Tucson, Arizona 85724
- GSK Investigational Site
Location: Indianapolis, Indiana 46202
|